A Study Evaluating the Presence and Concentration of BRIUMVI™ (Ublituximab) in Breast Milk

Natalizumab in Preventing Post-partum Relapses in Multiple Sclerosis

NCT03046251 ·Status: COMPLETED ·Phase: PHASE4

Study to Assess the Efficacy and Safety of Ublituximab in Participants With Relapsing Forms of Multiple Sclerosis (RMS) ( ULTIMATE 1 )

NCT03277261 ·Status: COMPLETED ·Phase: PHASE3

Study to Assess the Efficacy and Safety of Ublituximab in Participants With Relapsing Forms of Multiple Sclerosis (RMS)

NCT03277248 ·Status: COMPLETED ·Phase: PHASE3

Exploration of Novel Imaging Biomarkers on OCT for Ublituximab Treatment Response in Multiple Sclerosis

NCT06864936 ·Status: RECRUITING ·Phase: NA

9-month Study to Assess the Efficacy of Ofatumumab on Microglia in Patients With Relapsing Forms of Multiple Sclerosis

NCT04510220 ·Status: COMPLETED ·Phase: PHASE3

The Efficacy, Safety, and Tolerability of Laquinimod in Participants With Relapsing Remitting Multiple Sclerosis (RRMS)

NCT01707992 ·Status: COMPLETED ·Phase: PHASE3

Probiotic Chocolate Study in Multiple Sclerosis

NCT06475183 ·Status: COMPLETED ·Phase: NA

Study to Assess Effects of Ublituximab in Pediatric Participants With Relapsing Forms of Multiple Sclerosis

NCT07220252 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3

A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, Radiological and Clinical Effects of Subcutaneous Ublituximab in Participants With Relapsing Multiple Sclerosis (RMS)

NCT07211633 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS

NCT03650114 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

NCT06846281 ·Status: RECRUITING ·Phase: PHASE3

Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis

NCT06141473 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis

NCT02792218 ·Status: COMPLETED ·Phase: PHASE3

An Extension Study of Ublituximab in Participants With Relapsing Multiple Sclerosis

NCT04130997 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Longitudinal Study of Brain Atrophy in MS Patients Over 5 Years

NCT01847287 ·Status: COMPLETED

Ocrelizumab Effects on Physiological and Cognitive Changes in Multiple Sclerosis

NCT03025269 ·Status: COMPLETED

Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.

NCT02792231 ·Status: COMPLETED ·Phase: PHASE3

Immune Profiling During Ocrelizumab Treatment in Multiple Sclerosis

NCT03138525 ·Status: COMPLETED

A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.

NCT06372145 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Effect of Probiotics on Relapsing-Remitting Multiple Sclerosis

NCT07346924 ·Status: COMPLETED ·Phase: NA

Effects of Ublituximab on Motor Functions in Multiple Sclerosis

NCT06629428 ·Status: RECRUITING ·Phase: EARLY_PHASE1

A Study to Evaluate Rituximab in Adults With Relapsing Remitting Multiple Sclerosis

NCT00097188 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess the Effects of MK0812 on Disease Activity in Patients With Relapsing-Remitting Multiple Sclerosis as Measured by Magnetic Resonance Imaging (MRI)(0812-003)(COMPLETED)

NCT00239655 ·Status: TERMINATED ·Phase: PHASE2

Effect of Ocrelizumab on Neuroinflammation in Multiple Sclerosis as Measured by 11C-PBR28 MR-PET Imaging of Microglia Activation

NCT04230174 ·Status: COMPLETED ·Phase: PHASE4

The Neuroprotective Effect of Lamotrigine and Interferon Beta 1a in Patients With Relapsing-Remitting Multiple Sclerosis

NCT00917839 ·Status: UNKNOWN ·Phase: PHASE2